Gan&Lee | Briefing, News, Analysis, Research, Data

Gan&Lee

Gan&Lee is a high-tech biopharmaceutical enterprise integrating research

Gan & Lee Pharmaceutical Co., Ltd. was established in 1998, is a high-tech biopharmaceutical enterprise integrating research, development, production and sales. The company is a leading company at home and abroad in the development, research and production of biosynthetic human insulin and its analogs, and is a professional company focusing on biosynthetic human insulin analogs.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Jun 1, 1998

HQ location

Beijing, China

Legal name

Beijing Gan & Lee Biotechnology Co., Ltd.

Website

http://www.ganlee.com/

jianjun.gan@ganlee.com

Employees

1001-5000

All
News
Analysis
Research

Briefing May 20, 2022 10:53 AM · Healthcare

Haizheng pharmaceutical and Junshi biology signed a contract for commissioned production of Xinguan oral drug vv116

Briefing May 17, 2022 10:54 AM · Healthcare

Heavy bomb in the field of hypoglycemic! Lilly tirzepatide approved for listing

In-depth

Healthcare

EqualOcean Sector Quarterly Report - Healthcare Sectors

To help worldwide investors keep track of what is happening in each industry or sector and the related hot spots, we launched the EqualOcean Sector Quarterly Report series, which gathers notable information and statistics in each quarter.

Apr 07, 2022 01:44 PM

Briefing Mar 10, 2022 03:49 PM · Healthcare | Industrials | Consumer Staples

Liaoning Province held a working meeting to promote the listing of enterprises and launched the doubling plan for the listing of enterprises

Briefing Feb 23, 2022 06:59 PM · Healthcare | Financials | Technology

Pioneer fund welcomes the new general manager and the executive deputy general manager will no longer act as the general manager

Research

Financials, Technology, Healthcare

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Research

Healthcare, Consumer Staples, Technology

WIA2020 | Rising Tech Stars 2020: Global & China's 100

Dec 09, 2020 09:57 AM

Research

Healthcare

WIA2020 | Next 50 in Global Tech: Healthcare

Dec 09, 2020 09:39 AM

Research

Healthcare, Technology, Consumer Discretionary

Tech for Global, Globalization Footprints of the Established and the New

May 29, 2020 08:30 PM

Briefing Dec 10, 2021 05:49 PM · Consumer Staples | Technology | Consumer Discretionary

Haipurui: it plans to publicly issue corporate bonds of no more than RMB 1.5 billion to professional investors

Briefing Dec 06, 2021 04:49 PM · Healthcare | Consumer Staples | Technology

Humon shares: the 2021 ESOP has not yet started to purchase the company's shares

Briefing Nov 30, 2021 04:09 PM · Healthcare | Financials | Consumer Staples

Stellar Technology: 34.6 million shares pledged and extended by the controlling shareholder

Briefing Nov 26, 2021 11:38 AM · Healthcare

Ganli pharmaceutical won the bid for centralized procurement of insulin glargine injection

Healthcare, Consumer Staples

RLX Technology’s Net Profit Fell by 41.1% YoY

Government regulations and COVID-19 were restricting RLX Technology’s development.

May 20, 2022 03:03 PM

Healthcare

The Subsidiaries of Hengrui Pharma Gained Clinical Trial Approval Again

It will further complete the pipeline drug profiles of the pharma giant, Hengrui Pharma.

May 19, 2022 12:28 PM

Briefing Nov 26, 2021 11:30 AM

Special national collection of insulin: Ganli pharmaceutical Ganjing and asparagus insulin all reported the lowest prices: 48.71 yuan and 19.98 yuan

Briefing Nov 17, 2021 06:49 PM

Robin Li: Baidu has become the world's largest automated driving service provider.

Briefing Oct 12, 2021 05:23 PM · Healthcare | Automotive | Technology

Urban investment holding: the newly signed amount of real estate projects in the third quarter was about 304.3 million yuan

Healthcare

National Insulin Procurement is Implemented in Shandong Province, China

Chinese National Centralized Drug Procurement program is launched in 2019, aiming to lower drug prices and reduce drug expenditures by volume-based durg procurement.

May 19, 2022 10:56 AM

Healthcare

Chinese Biotech Startup Laekna Therapeutics Nets USD 61 Million in Series D Round

As a clinical-stage biotech company, Laekna has attracted several top investment institutions in the healthcare field.

May 18, 2022 08:36 PM

Briefing Sep 10, 2021 06:57 PM · Healthcare | Financials | Technology

Xin Guobin: accelerate the promotion of robots such as family services, education and entertainment

Briefing Aug 24, 2021 05:28 PM · Healthcare | Real Estate | Financials

Huitai medical: net profit in the first half of the year increased by 186.24% year-on-year

Briefing Aug 20, 2021 05:48 PM · Healthcare

During the 14th Five Year Plan period, China will restore 230 million mu of degraded grassland

Briefing Jul 23, 2021 10:13 AM · Healthcare

Pharmaceutical and biological stocks fell sharply in early trading

EqualOcean Analysis

EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.

Address

Beijing 9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China
Shanghai 2707-2708, AI Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China

New York Suite 2967, 29th Floor, 4 World Trade 150 Greenwich St, New York, NY 10006

About